ESTRELLA IMMUNOPHARMA INC
Q4 2023 13F Holders
Symbol
ESLAW
CUSIP
297584112
Type
Equity
Class
*W EXP 09/29/202
Num filings
17
Total reported value, excl. options
$239 k
Compare 2023 Q4 to
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q3
Manager
Report Date
Value ($000)
Shares
Option Type